From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Supplement
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. Luteolin inhibits several cytochrome P450 enzymes (including CYP3A4 and CYP1A2) and drug transporters, whereas St. John's Wort is a potent inducer of CYP3A4 and P-glycoprotein. Co-use creates opposing and unpredictable effects on the metabolism of many medications.
Mechanism. Luteolin is a CYP inhibitor; St. John's Wort is a CYP3A4/P-gp inducer, producing conflicting modulation of hepatic drug clearance.
Recommendation. Avoid relying on this combination to manage any medication regimen. Anyone on St. John's Wort for mood should consult a clinician before adding luteolin, since St. John's Wort itself has extensive drug interactions.
Stack Score
How it moves the number.
Effect on the composite score
If both Luteolin and St. John's Wort are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1Si D, et al. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metabolism and Disposition. 2009.Needs sourceNo link